NCT02246998 - Renal Effect of Stribild or Other Tenofovir DF-containing Regimens Compared to Ritonavir-boosted Atazanavir Plus Abacavir/Lamivudine in Antiretroviral Treatment-naive HIV-1 Infected Adults | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 15, 2014

Primary Completion Date

January 20, 2016

Study Completion Date

February 17, 2016

Conditions

HIV-1 Infection

Interventions

DRUG

STB

150/150/200/300 mg fixed dose combination (FDC) tablet administered orally once daily with food

DRUG

TVD

200/300 mg FDC tablet administered orally once daily with food

DRUG

ATR

600/200/300 mg FDC tablet administered orally once daily on an empty stomach at bedtime

DRUG

RTV

100 mg tablet administered orally once daily with food

DRUG

ATV

300 mg capsule administered orally once daily with food

DRUG

ABC/3TC

600/300 mg FDC tablet administered orally once daily with food

DRUG

Iohexol

1500 mg solution administered intravenously at baseline, and at Weeks 4, 8, 16, and 24

Trial Locations (20)

Unknown

Brussels

Ghent

Lyon

Paris

Rennes

Tourcoing

Dublin

Barcelona

Madrid

Seville

Birmingham

Bournemouth

Brighton

Bristol

Coventry

Liverpool

London

Manchester

Newcastle

Sheffield